Concepedia

Zhenchang Sun

ZS

Statistics

Publications

33

Citations

1.1K

H-Index

18

Active since

2013

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Zhengzhou University

The University of Texas MD Anderson Cancer Center

Nanjing General Hospital of Nanjing Military Command

Affiliated Hospital of Qingdao University

Zhenchang Sun is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, medicine, and chemotherapy.

Publications per year

2013–2022

33

Publications

33

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Xin Li, Mingzhi Zhang, Jiaqin Yan et al. · Journal of Hematology & Oncology · 2018 · 197 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

Xin Li, Yingying Cui, Zhenchang Sun et al. · Clinical Cancer Research · 2016 · 140 citations

Medicine, Oncology, Pharmacology +14

c‐Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T‐cell lymphoma

Linan Zhu, Xudong Zhang, Xiaorui Fu et al. · Journal of Cellular Biochemistry · 2019 · 67 citations

Medicine, Molecular Genetics, Oncology +15

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma

Xinhua Wang, Lei Zhang, Xiangli Liu et al. · JAMA Oncology · 2022 · 58 citations · Full text

Medicine, Oncology, Pharmacology +13

Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients

Zhi‐Yuan Zhou, Xiang Li, Changying Chen et al. · Annals of Hematology · 2014 · 52 citations

Medicine, Oncology, Pharmacotherapy +14

1–5 of 33